Named on one round in the feed.
Since 2026-03-26
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Emed eMed offers an at-home GLP-1 medication adherence program for individuals managing diabetes and weight loss. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2026-03-26 | [ LEAD ] |
No sector on record.